uniQure
QURE
#5098
Rank
NZ$2.91 B
Marketcap
NZ$46.17
Share price
-2.52%
Change (1 day)
84.79%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2026 (TTM): -NZ$0.35 Billion

According to uniQure's latest financial reports the company's current earnings are NZ$18.09 Million. In 2025 the company made an earning of -NZ$0.34 Billion, an increase over its 2024 earnings that were of -NZ$0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.35 Billion5.51%
2025 -NZ$0.34 Billion-18.47%
2024 -NZ$0.41 Billion-22.65%
2023 -NZ$0.53 Billion139.01%
2022 -NZ$0.22 Billion-138.54%
2021 NZ$0.56 B-335.29%
2020 -NZ$0.25 Billion13.88%
2019 -NZ$0.22 Billion49.51%
2018 -NZ$0.15 Billion4.55%
2017 -NZ$0.14 Billion12.65%
2016 -NZ$0.13 Billion-9.59%
2015 -NZ$0.14 Billion66.95%
2014 -NZ$79.77 Million30.8%
2013 -NZ$60.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$15.51 B-4,570.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.07 B-3,868.08%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-NZ$0.19 Billion-46.36%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-NZ$0.35 Billion-1.69%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.65 B-289.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-NZ$1.17 Billion 236.85%๐Ÿ‡บ๐Ÿ‡ธ USA